PubMed · PMID 10944864
Current and future trends in transfusion therapy.
PMID 10944864Journal Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology NursesYear 2000Authors 2DOI 10.1053/jpon.2000.8064
Abstract
The increase in intensive treatment for cancer has impacted blood product transfusion practices. Transfusion guidelines are primarily institution specific, but the general concepts and theories are universal. Blood product screening has decreased the risk of transfusion-acquired infections; however, the risk is not obsolete. This article reviews current approaches to platelet, white blood cell, and red blood cell transfusions, as well as risks associated with these therapies (e.g., infection and transfusion-associated graft-versus-host disease). Pertinent laboratory studies, patient assessment, blood product administration, and patient education is discussed.
The current approaches to platelet, white blood cell, and red blood cell transfusions are constantly changed and evaluated. Pediatric oncology nurses must stay up to date with these changes to provide optimal patient care.
Record details
| PMID | 10944864 |
|---|---|
| PMCID | not held |
| DOI | 10.1053/jpon.2000.8064 |
| Journal | Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses |
| Year | 2000 |
| Authors | C L Rossetto; J E McMahon |
| Licence | not stated |
| MeSH | Blood Component Transfusion; Humans; Neoplasms; Oncology Nursing; Pediatric Nursing; Practice Guidelines as Topic |
Source record
Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.